Development and preliminary validation of a platform for systematic, unbiased pre-screening of non-small cell lung cancer (NSCLC) across three community oncology practices.
Campbell Fontaine A, McAneny B, Tucker V, Koontz M, Trotter C, Paulson J, Svedman C, Pan A, Peguero J, Campos L. Development and preliminary validation of a platform for systematic, unbiased pre-screening of non-small cell lung cancer (NSCLC) across three community oncology practices. Journal Of Clinical Oncology 2024, 42: e23230-e23230. DOI: 10.1200/jco.2024.42.16_suppl.e23230.Peer-Reviewed Original ResearchNon-small cell lung cancerClinical trialsCommunity oncology practicesMedical oncologistsNon-small cell lung cancer ptsOncology practiceCell lung cancerClinical trial patient populationTrial patient populationTesting ratesPre-screening of patientsIdentification of eligible patientsAssessment of eligibilityECOG PSClinical trial sitesMetastatic statusEligible patientsLung cancerRoutine clinical workflowPatient populationOncology patientsPatientsOncologist assessmentGold standardTreatment history
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply